期刊文献+

肿瘤个体化药物治疗研究探讨 被引量:1

The Research of Tailored Medication for Tumor
下载PDF
导出
摘要 肿瘤个体化药物治疗可提高治疗疗效,避免药物的毒副作用和医疗资源的浪费。影响肿瘤药物治疗疗效有多方面因素,主要与肿瘤本身的生物学特性和肿瘤患者个体生物学特性有关。通过对这些特性的研究,可获得用于指导肿瘤个体化药物治疗客观检测指标。 Tailored medication for tumor can improve curative effect, avoid side effect and medical resources waste. The diverse factors which are related to tumor and tumor case biologic characteristics affect curative effect on tumor. The research for these characteristics may procure objective detect indicator to guide Tailor medication for tumor.
作者 顾康生
出处 《医学与哲学(B)》 2006年第7期53-54,共2页 Medicine & Philosophy(B)
关键词 肿瘤 个体化 药物治疗 tumor, individualization, medication
  • 相关文献

参考文献9

  • 1PULLARKAT S T,STOEHLMACHER J,GHADERI V,et al.Thymidylate synthase gene polymorphismdetermines response andtox-icity of5-FUchemotherapy[].Pharmacogenomics.2001
  • 2LYNCHTJ,BELL D W,SORDELLA R,et al.Activating mutations in the epidermal growth factorreceptor underlying responsiveness of non-small-cell lung cancer to gefitinib[].The New England Journal of Medicine.2004
  • 3.Addition of herceptintofirst line chemotherapyfor HER2overexpress-ing metastatic breast cancer increases anticancer activity:a random-ized,multinational controlled phase III trial[].Proc AmSoc Clin On-col.1998
  • 4VAN DE VIJVER MJ,HE Y D,VAN’T VEER LJ,et al.Agene-expressionsignature as a predictor of survival in breast cancer[].The New England Journal of Medicine.2002
  • 5TAMURA K,FUKUOKA M.Gefitinibin non-small cell lung cancer[].Expert Opin harmacother.2005
  • 6CHANGJ C,WOOTEN E C,TSI MELZON A,et al.Gene expression profilingfor the prediction of therapeutic response to docetaxel in pa-tients with breast cancer[].The Lancet.2003
  • 7RYUJ S,HONG Y C,HAN HS,et al.Association between polymor-phisms of ERCC1and XPDand survival in non-small-cell lung can-cer patients treated with cisplatin combination chemotherapy[].Lung Cancer.2004
  • 8HEI NRICH MC,CORLESS C L,BLANKE C,et al.KIT mutational analysis predicts clinical reaponse to STI571in patients with metastatic gastrointestinal stromal tumors(GISTs)[Abstract][].Proceedings of the American Society of Clinical Oncology.2002
  • 9WONG S F.Cetuxi mab:an epidermal growth factor receptor mono-clonal antibody for the treatment of colorectal cancer[].Clinical Therapeutics.2005

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部